<DOC>
	<DOCNO>NCT01103180</DOCNO>
	<brief_summary>The goal study examine effectiveness selective serotonin reuptake inhibitor ( SSRI ) escitalopram ( also know trade name `` Lexapro '' ) reduce desire self-harm actual self-harming among young adult borderline personality disorder also currently depress . Subjects receive either escitalopram placebo eight week . During time subject make weekly visit see psychiatrist record thought feeling several time day use electronic diary .</brief_summary>
	<brief_title>Selective Serotonin Reuptake Inhibitors ( SSRIs ) Borderline Personality Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Diagnosis Borderline Personality Disorder Current Major Depression Past 2 month SSRI use Past 6 month nonSSRI antidepressant use Past 2 month initiation psychotherapy Lifetime bipolar disorder , organic disorder , psychotic disorder Current alcohol drug dependence Current severe suicidal / homicidal ideation necessitate immediate medical intervention Currently pregnancy nurse Unable unwilling cooperate study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Selective Serotonin Reuptake Inhibitor</keyword>
	<keyword>Escitalopram</keyword>
	<keyword>Borderline Personality Disorder</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Self-harm</keyword>
</DOC>